ArticleCureus2025

Ravulizumab is Effective and Safe for Neuromyelitis Optica Spectrum Disorder Patients in Various Clinical Settings: A Single-Center Case Series with Concomitant Use of Rituximab.

Ryota AmanoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.